Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis – a multicenter, randomized, investigator-masked, parallel group study in Chinese patients

OBJECTIVES: Parallel comparison with 0.15% ganciclovir (GCV) ophthalmic gel to evaluate the effectiveness and safety of 0.15% GCV in situ ophthalmic gel for the treatment of herpes simplex keratitis (HSK). METHODS: This was a multicenter, randomized, investigator-masked, parallel group study. HSK pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tong, Gong, Lan, Sun, Xing-huai, Zhao, Nai-qing, Chen, Wei, Yuan, Hui-ping, Shao, Yan, Gao, Ming-hong, Tang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673863/
https://www.ncbi.nlm.nih.gov/pubmed/23761964
http://dx.doi.org/10.2147/DDDT.S42624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673863/
https://www.ncbi.nlm.nih.gov/pubmed/23761964
http://dx.doi.org/10.2147/DDDT.S42624

Ejemplares similares